Lipid-induced insulin resistance does not impair insulin access to skeletal muscle

American Journal of Physiology - Endocrinology and Metabolism

Volumn 308, Issue 11, 2015, Pages E1001-E1009

  Kolka, Cathryn M ^a   Richey, Joyce M ^a   Castro, Ana Valeria B ^a   Broussard, Josiane L ^a   Ionut, Viorica ^a   Bergman, Richard N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Glucose; Insulin; Interstitium; Lipid; Skeletal muscle

Indexed keywords

FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANINE MODEL; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE INFUSION; GLUCOSE TRANSPORT; GLYCEROL BLOOD LEVEL; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; ANIMAL; BLOOD; DOG; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; LIVER; METABOLISM;

ANIMALS; BLOOD GLUCOSE; DOGS; FATTY ACIDS, NONESTERIFIED; GLUCOSE CLAMP TECHNIQUE; INSULIN; INSULIN RESISTANCE; LIPIDS; LIVER; MALE; MUSCLE, SKELETAL;

EID: 84930828945     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00015.2015     Document Type: Article

References (52)

1. Ader M, Bergman RN. Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose. Am J Physiol Endocrinol Metab 266: E17–E25, 1994.
2. Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 100: 174–190, 2007.
3. Barrett EJ, Wang H, Upchurch CT, Liu Z. Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature. Am J Physiol Endocrinol Metab 301: E252–E263, 2011.
4. Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, Defronzo RA, Cusi K. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54: 1640–1648, 2005.
5. Boden G. Fatty acids and insulin resistance. In: Diabetes Mellitus: A Fundamental and Clinical Text, edited by LeRoith D, Olefsky JM, and Taylor SI. Philadelphia, PA: Lippincott, Williams, & Wilkins, 2004, p. 979–986.
6. Brechtel K, Dahl DB, Machann J, Bachmann OP, Wenzel I, Maier T, Claussen CD, Haring HU, Jacob S, Schick F. Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study. Magn Reson Med 45: 179–183, 2001.
7. Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhausl W, Roden M. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 55: 136–140, 2006.
8. Castillo C, Bogardus C, Bergman R, Thuillez P, Lillioja S. Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. J Clin Invest 93: 10–16, 1994.
9. Chavez AO, Kamath S, Jani R, Sharma LK, Monroy A, Abdul-Ghani MA, Centonze VE, Sathyanarayana P, Coletta DK, Jenkinson CP, Bai Y, Folli F, Defronzo RA, Tripathy D. Effect of short-term free Fatty acids elevation on mitochondrial function in skeletal muscle of healthy individuals. J Clin Endocrinol Metab 95: 422–429, 2010.
10. Chiu JD, Kolka CM, Richey JM, Harrison LN, Zuniga E, Kirkman EL, Bergman RN. Experimental hyperlipidemia dramatically reduces access of insulin to canine skeletal muscle. Obesity (Silver Spring) 17: 1486–1492, 2009.
11. Chiu JD, Richey JM, Harrison LN, Zuniga E, Kolka CM, Kirkman EL, Ellmerer M, Bergman RN. Direct administration of insulin into skeletal muscle reveals that the transport of insulin across the capillary endothelium limits the time course of insulin to activate glucose disposal. Diabetes 57: 828–835, 2008.
12. Clerk LH, Rattigan S, Clark MG. Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes 51: 1138–1145, 2002.
13. Clerk LH, Vincent MA, Jahn LA, Liu Z, Lindner JR, Barrett EJ. Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes 55: 1436–1442, 2006.
14. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103: 253–259, 1999.
15. Eggleston EM, Jahn LA, Barrett EJ. Early microvascular recruitment modulates subsequent insulin-mediated skeletal muscle glucose metabolism during lipid infusion. Diabetes Care 36: 104–110, 2013.
16. Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36: 914–924, 1987.
17. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48: 1270–1274, 1999.
18. Hayashi H, Nutting DF, Fujimoto K, Cardelli JA, Black D, Tso P. Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J Lipid Res 31: 1613–1625, 1990.
19. Herkner H, Klein N, Joukhadar C, Lackner E, Langenberger H, Frossard M, Bieglmayer C, Wagner O, Roden M, Muller M. Transcapillary insulin transfer in human skeletal muscle. Eur J Clin Invest 33: 141–146, 2003.
20. Hoeg LD, Sjoberg KA, Jeppesen J, Jensen TE, Frosig C, Birk JB, Bisiani B, Hiscock N, Pilegaard H, Wojtaszewski JF, Richter EA, Kiens B. Lipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling. Diabetes 60: 64–73, 2011.
21. Hoeks J, van Herpen NA, Mensink M, Moonen-Kornips E, van Beurden D, Hesselink MK, Schrauwen P. Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance. Diabetes 59: 2117–2125, 2010.
22. Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, Bulchand S, Knotts TA, Shui G, Clegg DJ, Wenk MR, Pagliassotti MJ, Scherer PE, Summers SA. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acidinduced ceramide biosynthesis in mice. J Clin Invest 121: 1858–1870, 2011.
23. Hussey SE, Lum H, Alvarez A, Cipriani Y, Garduno-Garcia J, Anaya L, Dube J, Musi N. A sustained increase in plasma NEFA upregulates the Toll-like receptor network in human muscle. Diabetologia 57: 582–591, 2014.
24. Huxley VH, Scallan J. Lymphatic fluid: exchange mechanisms and regulation. J Physiol 589: 2935–2943, 2011.
25. Ikomi F, Hunt J, Hanna G, Schmid-Schonbein GW. Interstitial fluid, plasma protein, colloid, and leukocyte uptake into initial lymphatics. J Appl Physiol (1985) 81: 2060–2067, 1996.
26. Jensen SM, Hansen HS, Johansen T, Malmlof K. In vivo and in vitro microdialysis sampling of free fatty acids. J Pharm Biomed Anal 43: 1751–1756, 2007.
27. Kolka CM, Bergman RN. The barrier within: endothelial transport of hormones. Physiology (Bethesda) 27: 237–247, 2012.
28. Kolka CM, Harrison LN, Lottati M, Chiu JD, Kirkman EL, Bergman RN. Diet-induced obesity prevents interstitial dispersion of insulin in skeletal muscle. Diabetes 59: 619–626, 2009.
29. Krssak M, Falk PK, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M, Shulman GI. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42: 113–116, 1999.
30. Kubota T, Kubota N, Kumagai H, Yamaguchi S, Kozono H, Takahashi T, Inoue M, Itoh S, Takamoto I, Sasako T, Kumagai K, Kawai T, Hashimoto S, Kobayashi T, Sato M, Tokuyama K, Nishimura S, Tsunoda M, Ide T, Murakami K, Yamazaki T, Ezaki O, Kawamura K, Masuda H, Moroi M, Sugi K, Oike Y, Shimokawa H, Yanagihara N, Tsutsui M, Terauchi Y, Tobe K, Nagai R, Kamata K, Inoue K, Kodama T, Ueki K, Kadowaki T. Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab 13: 294–307, 2011.
31. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 85: 1844–1852, 1990.
32. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 307: 384–387, 2005.
33. Nowotny B, Zahiragic L, Krog D, Nowotny PJ, Herder C, Carstensen M, Yoshimura T, Szendroedi J, Phielix E, Schadewaldt P, Schloot NC, Shulman GI, Roden M. Mechanisms underlying the onset of oral lipidinduced skeletal muscle insulin resistance in humans. Diabetes 62: 2240–2248, 2013.
34. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14: 263–283, 1998.
35. Rattigan S, Richards SM, Keske MA. Microvascular contributions to insulin resistance. Diabetes 62: 343–345, 2013.
36. Rattigan S, Zhang L, Mahajan H, Kolka CM, Richards SM, Clark MG. Factors influencing the hemodynamic and metabolic effects of insulin in muscle. Curr Diabetes Rev 2: 61–70, 2006.
37. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97: 2859–2865, 1996.
38. Sandqvist M, Strindberg L, Schmelz M, Lonnroth P, Jansson PA. Impaired delivery of insulin to adipose tissue and skeletal muscle in obese women with postprandial hyperglycemia. J Clin Endocrinol Metab 96: E1320–E1324, 2011.
39. Schmitz-Peiffer C. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 12: 583–594, 2000.
40. Sherman AI, Ter-Pogossian M. Lymph-node concentration of radioactive colloidal gold following interstitial injection. Cancer 6: 1238–1240, 1953.
41. Sjöstrand M, Gudbjörnsdottir S, Holmäng A, Lönn L, Strindberg L, Lönnroth P. Delayed transcapillary transport of insulin to muscle interstitial fluid in obese subjects. Diabetes 51: 2742–2748, 2002.
42. Sjöstrand M, Holmäng A, Lönnroth P. Measurement of interstitial insulin in human muscle. Am J Physiol Endocrinol Metab 276: E151–E154, 1999.
43. Skalak TC, Schmid-Schonbein GW, Zweifach BW. New morphological evidence for a mechanism of lymph formation in skeletal muscle. Microvasc Res 28: 95–112, 1984.
44. Sloop CH, Dory L, Roheim PS. Interstitial fluid lipoproteins. J Lipid Res 28: 225–237, 1987.
45. Szendroedi J, Frossard M, Klein N, Bieglmayer C, Wagner O, Pacini G, Decker J, Nowotny P, Müller M, Roden M. Lipid-induced insulin resistance is not mediated by impaired transcapillary transport of insulin and glucose in humans. Diabetes 61: 3176–3180, 2012.
46. Szendroedi J, Yoshimura T, Phielix E, Koliaki C, Marcucci M, Zhang D, Jelenik T, Müller J, Herder C, Nowotny P, Shulman GI, Roden M. Role of diacylglycerol activation of PKCtheta in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci USA 111: 9597–9602, 2014.
47. Utsunomiya K. Treatment strategy for type 2 diabetes from the perspective of systemic vascular protection and insulin resistance. Vasc Health Risk Manag 8: 429–436, 2012.
48. Vincent MA, Clerk LH, Lindner JR, Klibanov AL, Clark MG, Rattigan S, Barrett EJ. Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes 53: 1418–1423, 2004.
49. Wang H, Liu Z, Li G, Barrett EJ. The vascular endothelial cell mediates insulin transport into skeletal muscle. Am J Physiol Endocrinol Metab 291: E323–E332, 2006.
50. Wang XL, Zhang L, Youker K, Zhang MX, Wang J, LeMaire SA, Coselli JS, Shen YH. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes 55: 2301–2310, 2006.
51. Wiig H, Swartz MA. Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev 92: 1005–1060, 2012.
52. Zawieja SD, Wang W, Wu X, Nepiyushchikh ZV, Zawieja DC, Muthuchamy M. Impairments in the intrinsic contractility of mesenteric collecting lymphatics in a rat model of metabolic syndrome. Am J Physiol Heart Circ Physiol 302: H643–H653, 2012.